At the news
? NEUTRALIMPACT 2/10 144 filed Jun 16, 2026 at 16:53 ET
Officer Jeffrey S. Farrow filed a Form 144 to sell 14,396 shares of Tarsus Pharmaceuticals common stock, valued at approximately $877K, to cover tax obligations from restricted stock vesting. This is a routine sell-to-cover transaction, not a discretionary sale, and carries no bearish signal.
- Insider Jeffrey S. Farrow (Officer) filed Form 144 to sell 14,396 shares.
- Estimated sale value: $877,459.23 based on a price of ~$60.96/share.
- Shares originate from restricted stock vesting on June 15, 2026.
- Sale is to cover tax withholding obligations, not a discretionary cash-out.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access